A public university hospital in Bamako with a medical oncology service that grew out of its haemato-oncology department. It hosts the Bamako cancer registry and the country's main pathology laboratory, and dispenses free anticancer medicines supplied by the state.
The African Cancer Registry Network's undated page on the Bamako registry describes CHU du Point G as a university hospital with all specialities, including medical oncology developed from haemato-oncology, and its pathology laboratory as the main one in the country, doing most of the pathology work for Bamako and beyond. The cancer registry sits in its pathology department. The coordinates are an approximate point for the hospital.
A study by its hospital pharmacy of 1,490 prescriptions for 301 patients from January to June 2019 found that FOLFOX, AC and paclitaxel with carboplatin were the most prescribed regimens, that on average 63.64% of the anticancer medicines were available, and that eight medicines ran out of stock, for up to 120 days. The authors describe the state supplying anticancer medicines worth 285 million CFA francs a year so that chemotherapy is free. In November 2026 the Minister of Health said that 43.42% of prostate cancers diagnosed in its urology service were already metastatic.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/